MedPath

肇庆星湖制药有限公司

Ownership
-
Established
1991-10-28
Employees
-
Market Cap
-
Website
www.xinghuzhiyao.cn

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

77

NMPA:77

Drug Approvals

Nifedipine Tablets

Product Name
硝苯地平片
Approval Number
国药准字H44021788
Approval Date
Mar 4, 2020
NMPA

Hymecromone Capsules

Product Name
羟甲香豆素胶囊
Approval Number
国药准字H44021833
Approval Date
Dec 5, 2019
NMPA

Vitamin B1 Tablets

Product Name
维生素B1片
Approval Number
国药准字H44021782
Approval Date
Dec 5, 2019
NMPA

蛇胆川贝液

Approval Number
国药准字Z44021461
Approval Date
Dec 5, 2019
NMPA

Propafenone Hydrochloride Tablets

Product Name
盐酸普罗帕酮片
Approval Number
国药准字H44023621
Approval Date
Dec 5, 2019
NMPA

Berberine Hydrochloride Tablets

Product Name
盐酸小檗碱片
Approval Number
国药准字H44021790
Approval Date
Dec 5, 2019
NMPA

Vitamin C Tablets

Product Name
维生素C片
Approval Number
国药准字H44021785
Approval Date
Dec 5, 2019
NMPA

Cimetidine Tablets

Product Name
西咪替丁片
Approval Number
国药准字H44021787
Approval Date
Dec 5, 2019
NMPA

Vitamin B6 Tablets

Product Name
维生素B6片
Approval Number
国药准字H44021784
Approval Date
Dec 5, 2019
NMPA

Nitrendipine Tablets

Product Name
尼群地平片
Approval Number
国药准字H44021827
Approval Date
Nov 22, 2019
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 8
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.